14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session II : Receptor <strong>signaling</strong> <strong>and</strong> G proteins Poster II, 5<br />

Dysregulation of GABAergic Neurotransmission in Mood Disorders<br />

Hendrik Bielau1, Tomasz Gos1, Christian Mawrin2, Kurt Trübner3, Ralf Brisch1,<br />

Gabriela Meyer-Lotz1, Henrik Dobrowolny1, Bruno Baumann1, Hans-Gert Bernstein1,<br />

Bernhard Bogerts1<br />

1Department of Psychiatry, Psychotherapy und Psychosomatic Medicine <strong>and</strong> 2Institute<br />

of Neuropathology; Otto-von-Guericke-University, Leipziger Str. 44, 39120 Magdeburg,<br />

Germany, E-mail: Hendrik.Bielau@Medizin.Uni-Magdeburg.de<br />

3Institute of Legal Medicine, University of Essen, Hufel<strong>and</strong>str. 55, 45122 Essen,<br />

Germany<br />

Alterations of GABAergic neurotransmission are assumed to play a crucial roll in the<br />

pathophysiology of mood disorders. GABA acts via binding to A <strong>and</strong> B receptors, whereas<br />

the B receptor is G-protein-coupled. Glutamatdecarboxylase (GAD) is the key enzyme of<br />

GABA synthesis. The goal of <strong>our</strong> postmortem investigation was the bihemispherical<br />

immunohistochemical staining of GAD neurons in brain structures which are important for<br />

mood regulation. In 20 brains of patients with mood disorders <strong>and</strong> 19 controls (C) an<br />

immunohistochemical staining of GAD-65/67 neurons was performed in dorsolateral<br />

prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex, superior temporal gyrus,<br />

hippocampus <strong>and</strong> medial <strong>and</strong> lateral thalamus with consecutive determination of neuronal<br />

density. In the diagnosis group were 11 patients with bipolar disorder (BD) <strong>and</strong> 9 patients<br />

with major depressive disorder (MDD). The data were tested statistically using ANOVA und<br />

post-hoc Tukey tests. The evaluation revealed significant differences between the groups (C,<br />

BD, MDD) in dorsolateral prefrontal cortex, orbitofrontal cortex, superior temporal gyrus <strong>and</strong><br />

hippocampus. The post-hoc tests demonstrated higher neuronal densities in unipolar patients<br />

compared to bipolar patients <strong>and</strong> controls in dorsolateral prefrontal cortex, superior temporal<br />

gyrus <strong>and</strong> hippocampus. In the orbitofrontal cortex a higher neuronal density was found in<br />

bipolar <strong>and</strong> unipolar patients compared to controls. In the bipolar group dose equivalents of<br />

antidepressants given prior to death correlated positively with the neuronal density in the<br />

hippocampus. In conclusion, the current data on GAD-65/67 point on a dysregulation of the<br />

GABAergic system in mood disorders. Possibly, existing deficits of GABAergic<br />

neurotransmission will be compensated or overcompensated by antidepressants. Moreover,<br />

preliminary data point toward a diminished density of GAD terminals.<br />

- 132 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!